Skip to content

t2biosystems-logo t2biosystems-logo

Stewardship Impact: Case Studies
  • Investors
  • Technical Support
  • Contact Us
Stewardship Impact: Case Studies
  • Products & Technology
    • T2Dx Instrument
      • T2Dx 2.019
    • T2Bacteria Panel
      • NTAP Reimbursement
    • T2Candida Panel
    • T2MR Technology
    • Product Pipeline
      • BARDA
      • T2Resistance Panel
      • T2Lyme Panel
      • T2Cauris Panel
  • Clinicians
    • Sepsis Committee
    • Infectious Diseases
    • Hospital Pharmacy
    • In the Lab
    • Emergency Medicine
    • Hospital Administration
  • Stewardship Experience
    • US Hospitals
      • Henry Ford Health System
      • Huntsville Hospital
      • Lee Health
      • Riverside Community Hospital 
      • Robert Wood Johnson Medical School
      • UPMC
    • Outside the US Hospitals
      • Gemelli Hospital, Italy
      • Gregorio Marañón Hospital in Madrid, Spain
      • La Paz Hospital University, Spain
      • Rigshospitalet, Denmark
  • News & Resources
    • In the News
    • Publications and Presentations
    • Weekly Case Studies
  • About T2
    • Our Company
    • Our Mission
    • Leadership
    • Careers
    • Events
    • Research Partnerships
    • International Distributors
    • FAQ
    • Media Resources
search-toggle
backspace
  • In the News
  • Publications and Presentations
  • Weekly Case Studies
  • Home
  • News & Resources

News & Resources

Share the post "News & Resources"

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • E-mail

JOIN THE MAILING LIST!

Media Contact

Gina Kent
610-455-2763
gkent@vaultcommunications.com

Contact us

T2 Biosystems
101 Hartwell Avenue
Lexington, MA 02421
Phone: 781-457-1200
Fax: 781-357-3080
Toll Free: 877-504-T2T2 (8282)

Email Us

T2 Biosystems OVERVIEW

T2 Biosystems, an emerging leader in the field of in vitro diagnostics, is dedicated to saving lives and reducing the cost of healthcare by empowering clinicians to effectively treat patients faster than ever before. T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today.

The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products are considered investigational and for research use only.

T2 Biosystems®, T2MR®, T2Bacteria®, T2Candida®, and T2Dx® are registered trademarks of T2 Biosystems, Inc. "T2Biosystems" and the T2 Biosystems, Inc. logo design are registered trademarks or trademarks of T2Biosystems, Inc. All software and documentation is subject to T2 Biosystems, Inc. copyrights. All rights reserved. T2Direct Diagnostics™, T2HemoStat™, and T2Plex™ are trademarks of T2 Biosystems, Inc.

© 2019 T2 Biosystems, Inc.

Join in on Twitter

Tweets by @t2bio

Sitemap

  • T2MR Technology
  • T2Bacteria Panel
  • T2Candida Panel
  • Product Pipeline
  • T2Dx Instrument
  • Terms of Use & Privacy Policy
  • Standard Terms & Conditions
  • About T2
  • Investors
  • Technical Support
  • Careers
  • Contact Us
  • Conflict Minerals Report
  • T2 Compliance Program
  • Declaration of Compliance

 

Follow Us on Social

  • LinkedIn
  • Twitter